Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
17.8M
-
Shares change
-
+1.96M
-
Total reported value, excl. options
-
$1.13B
-
Value change
-
+$125M
-
Put/Call ratio
-
9.86
-
Number of buys
-
102
-
Number of sells
-
-71
-
Price
-
$63.11
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2023
212 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q2 2023.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.8M shares
of 835M outstanding shares and own 2.14% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.96M shares), RENAISSANCE TECHNOLOGIES LLC (1.65M shares), Robeco Institutional Asset Management B.V. (1.45M shares), VANGUARD GROUP INC (1.03M shares), GOLDMAN SACHS GROUP INC (970K shares), DIMENSIONAL FUND ADVISORS LP (830K shares), STATE STREET CORP (824K shares), GQG Partners LLC (722K shares), MORGAN STANLEY (650K shares), and BANK OF AMERICA CORP /DE/ (545K shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.